Search results
Results from the WOW.Com Content Network
The National Institutes of Health Stroke Scale, or NIH Stroke Scale (NIHSS), is a tool used by healthcare providers to objectively quantify the impairment caused by a stroke and aid planning post-acute care disposition, though was intended to assess differences in interventions in clinical trials. The NIHSS was designed for the National ...
The Cincinnati Prehospital Stroke Scale (abbreviated CPSS) is a system used to diagnose a potential stroke in a prehospital setting. [1] It tests three signs for abnormal findings which may indicate that the patient is having a stroke.
All NIH Institutes and Centers are involved with OSC in the design, implementation, and evaluation of Common Fund programs. [15] commonfund.nih.gov: Office of Technology Transfer: OTT manages the wide range of NIH and FDA intramural inventions as mandated by the Federal Technology Transfer Act and related legislation.
The Los Angeles Prehospital Stroke Screen (abbreviated LAPSS) is a method of identifying potential stroke patients in a pre-hospital setting. [1] Screening criteria
The researchers sought to predict the risk of major cardiac events with a 30-year follow-up period using a blood test. At the time, the average participant age was 54.7 years.
Further, PROMIS tools allow for computer adaptive testing, efficiently achieving precise measurement of health status domains with few items. There are PROMIS measures for both adults and children. PROMIS was established in 2004 with funding from the National Institutes of Health (NIH) as one of the initiatives of the NIH Roadmap for Medical ...
Edward Taub in 2014. Edward Taub (born 1931, Brooklyn New York) [1] is a behavioral neuroscientist on the faculty at the University of Alabama at Birmingham.He is best known for his involvement in the Silver Spring monkeys case, for making discoveries in the area of neuroplasticity, and developing constraint-induced movement therapy; a family of techniques which helps the rehabilitation of ...
Beyond glucose control and weight loss, benefits like a reduction in the risk of stroke, heart attacks, major cardiac events and kidney disease were expected, since some GLP-1 medicines have ...